In this Issue:
Postsplenectomy vincristine for refractory/relapsed ITP
PNH and telomere length predict immunosuppressive response in paediatric aplastic anaemia
IVIG and thromboembolic events in haematological malignancies
Sirolimus in relapsed/refractory autoimmune cytopenias
Tosedostat with cytarabine or decitabine in older AML/MDS
Obinutuzumab in symptomatic, previously untreated CLL
FCR achieves long-term disease-free survival in IGHV-mutated CLL
Bleeding-related adverse events in ibrutinib-treated CLL
Ibrutinib monotherapy in relapsed/refractory B-cell malignancies
Please login below to download this issue (PDF)